NCT02180100View on ClinicalTrials.gov

Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Vulvovaginal Candidiasis
Interventions
DRUG

Terconazole Vaginal Suppository

Terconazole Vaginal Suppository inserted intravaginally once daily before bedtime for 6 consecutive days

DRUG

Fluconazole

orally Fluconazole 150 mg (Pfizer Pharmaceuticals) at day 1 and day 4.

Trial Locations (1)

518036

Peking University Shenzhen Hosptal, Shenzhen

All Listed Sponsors
collaborator

Shanghai Shyndec Pharmaceutical Co., Ltd.

INDUSTRY

lead

Peking University Shenzhen Hospital

OTHER

NCT02180100 - Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis | Biotech Hunter | Biotech Hunter